Paper · 29482575
i-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleases.
Ohtsuka M and 9 others. Genome Biol, 2018. Cited by 166 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. i-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleases. Papers, record 29482575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29482575
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Proteins | Major topic |
| CRISPR-Cas Systems | Major topic |
| Endonucleases | Major topic |
| Gene Editing | Major topic |
| Animals | |
| CRISPR-Associated Proteins | |
| Electroporation | |
| Female | |
| Forkhead Transcription Factors | |
| Gene Knock-In Techniques | |
| Mice, Inbred Strains | |
| Mice, Knockout | |
| Mice, Transgenic | |
| Microinjections | |
| Ovary | |
| Pregnancy | |
| Sequence Deletion | |
| Endodeoxyribonucleases |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 16K18821 | Japan Society for the Promotion of Science | International | PubMed | |
| 15K14371 | Japan Society for the Promotion of Science | International | PubMed | |
| 16H05049 | Japan Society for the Promotion of Science | International | PubMed | |
| 2014 | Tokai University School of Medicine Research Aid | International | PubMed | |
| 2016-2017 | Tokai University School of Medicine Project Research | International | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 29,490,686 | Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology. | https://conductscience.org/library/papers/29490686 |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,351,759 | Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes. | Methods | 2017 | https://conductscience.org/library/papers/28351759 | PubMed |
| 2 | 26,422,227 | Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. | Cell | 2015 | https://conductscience.org/library/papers/26422227 | PubMed |
| 3 | 27,158,268 | Roles for retrotransposon insertions in human disease. | Mob DNA | 2016 | https://conductscience.org/library/papers/27158268 | PubMed |
| 4 | 23,643,243 | One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. | Cell | 2013 | https://conductscience.org/library/papers/23643243 | PubMed |
| 5 | 27,384,229 | CRISPR: a versatile tool for both forward and reverse genetics research. | Hum Genet | 2016 | https://conductscience.org/library/papers/27384229 | PubMed |
| 6 | 22,002,806 | A deletion in a cis element of Foxe3 causes cataracts and microphthalmia in rct mice. | Mamm Genome | 2011 | https://conductscience.org/library/papers/22002806 | PubMed |
| 7 | 11,476,355 | Culture of preimplantation embryos and its long-term effects on gene expression and phenotype. | Hum Reprod Update | 2001 | https://conductscience.org/library/papers/11476355 | PubMed |
| 8 | 26,137,492 | Precision Medicine for Continuing Phenotype Expansion of Human Genetic Diseases. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26137492 | PubMed |
| 9 | 16,199,865 | Severe defects in proliferation and differentiation of lens cells in Foxe3 null mice. | Mol Cell Biol | 2005 | https://conductscience.org/library/papers/16199865 | PubMed |
| 10 | 25,819,794 | Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease. | Genetics | 2015 | https://conductscience.org/library/papers/25819794 | PubMed |
1 to 10 of 29
See all 29 referencesCited by119
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,661,411 | Nucleases and Their Inhibitors: Exploring Biological Roles, Industrial Applications, and Challenges in Heterologous Expression. | Biotechnol J | 2026 | https://conductscience.org/library/papers/42661411 | PubMed |
| 42,536,701 | Branched-chain amino acid transaminase 1-mediated pathway promotes proline-dependent collagen production in cardiac myofibroblasts. | J Clin Invest | 2026 | https://conductscience.org/library/papers/42536701 | PubMed |
| 42,290,195 | Clarifying Frizzled 2 function in development through genetically validated mouse models. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/42290195 | PubMed |
| 42,201,943 | A portable, ultra-low cost, open-source, pedal-controlled microinjector for laboratory use. | PLoS One | 2026 | https://conductscience.org/library/papers/42201943 | PubMed |
| 42,084,361 | Constitutive interferon epsilon expression shapes antiviral epithelial states in the female reproductive tract and intestine. | mBio | 2026 | https://conductscience.org/library/papers/42084361 | PubMed |
| 41,972,436 | PSMA8-Containing 20S Proteasome Regulates Spermiogenesis and Male Fertility. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41972436 | PubMed |
| 41,813,164 | Effect of post-weaning diet on hibernation occurrence in Syrian hamsters. | Exp Anim | 2026 | https://conductscience.org/library/papers/41813164 | PubMed |
| 41,727,189 | Reduced Akr1b7 signaling drives ovarian aging and reproductive dysfunction. | iScience | 2026 | https://conductscience.org/library/papers/41727189 | PubMed |
| 41,709,464 | Non-invasive ovulation tracking enables genetic engineering in wild rodents. | Cell Rep Methods | 2026 | https://conductscience.org/library/papers/41709464 | PubMed |
| 41,634,336 | DGCR8 regulates multiple processes of transcription coupled nucleotide excision repair. | Sci Rep | 2026 | https://conductscience.org/library/papers/41634336 | PubMed |
1 to 10 of 119
See all 119 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29482575
GET https://conductscience.org/api/papers/v1/29482575/references?page=2